Immunization

The FDA approved the pneumococcal 15-valent conjugate vaccine for the prevention of invasive pneumococcal disease in infants and children.

The FDA announced the EUA of both Moderna and Pfizer-BioNTech COVID-19 vaccines for use in children aged 6 months and older.

The program administered 60 vaccines to patients referred by their primary care physicians.

A majority of survey respondents were willing to receive a COVID-19 vaccine.

If authorized, it will be the fourth COVID-19 vaccine available in the Untied States.

GSK plc announced FDA approval of the PRIORIX vaccine for prevention of measles, mumps, and rubella.

During COVID-19, pharmacy technicians helped keep immunization programs running.

Results address the concern that COVID-19 vaccination might not be effective among those living with HIV.

Pfizer-BioNTech reports strong immune response, high efficacy, and favorable safety in third dose of the COVID-19 vaccine.

Research suggests that COVID-19 vaccination may serve a therapeutic effect, possibly reducing the risk of developing long COVID when administered to those currently infected.

The vaccine also prevented nearly 9 million symptomatic cases.

The company is utilizing this platform to address new COVID-19 variants, combination vaccines, and potentially prevent HIV.

Study shows that 10% of minorities refused COVID-19 vaccines because of past racial discrimination experiences

The pandemic underscored the incredible power of vaccination.

William J. Muller, MD, PhD, discusses COVID-19 vaccinations for children and what is on the horizon for a potential RSV vaccine.

Vaccination errors are common but preventable mistakes.

What pediatric health care providers should know about the 2022 Advisory Committee on Immunization Practices schedule updates.

Some parents are still hesitant about vaccinating their children.

A pilot program utilized student pharmacists, medical residents, and nurses to facilitate well-child visits.

There’s more to vaccines than just COVID-19.

Recent changes in regulations mean that pharmacists are able to administer vaccines to children as young as 3.

Multiple pharmaceutical companies are investigating the application of mRNA technology to develop vaccines that treat and prevent multiple conditions, from influenza to cancer and beyond.

Results of a recent preclinical study provide proof of concept that an mRNA HIV vaccine is safe, immunogenic, and induces CD4–T-cell responses.

For more than 70 years, vaccination has been a public health strategy for disease mitigation. Even in populations often considered “vulnerable”—children and pregnant women—vaccination is strongly recommended and commonly embraced.

Vaccines are important for everyone, but they’re critical for adults older than 65 years.